TAP provides Delaware bioscience businesses access to high-end research technologies at reduced rates. Eligible facilities include Bioimaging, DNA Sequencing & Genotyping, Bioinformatics, NMR, and Mass Spectrometry. This program supports the technological advancement of Delaware's bioscience sector by making cutting-edge resources more accessible, with funding up to $5,000 per year per core facility.